BIO Europe 2025 | Insilico Advances Longevity Research with Breakthrough Multiparameter-Optimized Cardiometabolic Assets Powered by Generative AI
In a groundbreaking announcement set to reshape the landscape of cardiometabolic therapeutics, Insilico Medicine, a clinical-stage biotechnology company propelled by ...
